The Food and Drug Administration on Tuesday authorized a second booster dose of the Pfizer-BioNTech and the Moderna Covid-19 vaccines for adults ages 50 and older. People are eligible to get the additional dose at least four months after receiving their first booster, the FDA said in a statement. Dr. Rochelle Walensky, director of the …
Continue reading “FDA authorizes second booster of Pfizer/BioNTech COVID shot”









